Literature DB >> 13679116

Is mental retardation a defect of synapse structure and function?

Magdalena Chechlacz1, Joseph G Gleeson.   

Abstract

Mental retardation is believed to be a result of alterations in molecular pathways underlying neuronal processes involved in cognitive functions. It is not fully understood, however, which molecular pathways are critical for cognitive mechanisms. Furthermore, whether mental retardation is a developmental or ongoing disorder of cognitive functions is unknown. Answering these questions will help elucidate the etiology of mental retardation and possibly lead to new therapies. Several recently published studies suggested that mental retardation might be caused by defects in synapse structure and function. Four genes mutated in families with mental retardation encode proteins known as Rho guanine nucleotide exchange factor 6, oligophrenin-1, p21-activated kinase, and guanine dissociation inhibitor 1. Each of these interacts with various guanine nucleotide-binding proteins involved in signaling pathways that regulate the actin cytoskeleton, neurite outgrowth, neurotransmitter release, and dendritic spine morphology. The goal is to understand the roles of these genes in normal cognitive functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 13679116     DOI: 10.1016/s0887-8994(03)00152-8

Source DB:  PubMed          Journal:  Pediatr Neurol        ISSN: 0887-8994            Impact factor:   3.372


  20 in total

1.  Reduced cortical folding in mental retardation.

Authors:  Y Zhang; Y Zhou; C Yu; L Lin; C Li; T Jiang
Journal:  AJNR Am J Neuroradiol       Date:  2010-01-14       Impact factor: 3.825

Review 2.  Reversing synapse loss in Alzheimer's disease: Rho-guanosine triphosphatases and insights from other brain disorders.

Authors:  Roger Lefort
Journal:  Neurotherapeutics       Date:  2015-01       Impact factor: 7.620

3.  Signal transduction in Alzheimer disease: p21-activated kinase signaling requires C-terminal cleavage of APP at Asp664.

Authors:  Thuy-Vi V Nguyen; Veronica Galvan; Wei Huang; Surita Banwait; Huidong Tang; Junli Zhang; Dale E Bredesen
Journal:  J Neurochem       Date:  2007-11-06       Impact factor: 5.372

4.  Bdnf overexpression in hippocampal neurons prevents dendritic atrophy caused by Rett-associated MECP2 mutations.

Authors:  Jennifer L Larimore; Christopher A Chapleau; Shinichi Kudo; Anne Theibert; Alan K Percy; Lucas Pozzo-Miller
Journal:  Neurobiol Dis       Date:  2009-01-03       Impact factor: 5.996

5.  Normal protein composition of synapses in Ts65Dn mice: a mouse model of Down syndrome.

Authors:  Fabian Fernandez; Jonathan C Trinidad; Martina Blank; Dong-Dong Feng; Alma L Burlingame; Craig C Garner
Journal:  J Neurochem       Date:  2009-04-22       Impact factor: 5.372

Review 6.  Influence of the NR3A subunit on NMDA receptor functions.

Authors:  Maile A Henson; Adam C Roberts; Isabel Pérez-Otaño; Benjamin D Philpot
Journal:  Prog Neurobiol       Date:  2010-01-25       Impact factor: 11.685

7.  A mental retardation gene, motopsin/neurotrypsin/prss12, modulates hippocampal function and social interaction.

Authors:  Shinichi Mitsui; Yoji Osako; Fumiaki Yokoi; Mai T Dang; Kazunari Yuri; Yuqing Li; Nozomi Yamaguchi
Journal:  Eur J Neurosci       Date:  2009-12-10       Impact factor: 3.386

8.  Glia co-culture with neurons in microfluidic platforms promotes the formation and stabilization of synaptic contacts.

Authors:  Mingjian Shi; Devi Majumdar; Yandong Gao; Bryson M Brewer; Cody R Goodwin; John A McLean; Deyu Li; Donna J Webb
Journal:  Lab Chip       Date:  2013-08-07       Impact factor: 6.799

Review 9.  Dendritic spine pathology and thrombospondin-1 deficits in Down syndrome.

Authors:  Maria D Torres; Octavio Garcia; Cindy Tang; Jorge Busciglio
Journal:  Free Radic Biol Med       Date:  2017-09-28       Impact factor: 7.376

10.  Inhibition of RhoA pathway rescues the endocytosis defects in Oligophrenin1 mouse model of mental retardation.

Authors:  Malik Khelfaoui; Alice Pavlowsky; Andrew D Powell; Pamela Valnegri; Kenneth W Cheong; Yann Blandin; Maria Passafaro; John G R Jefferys; Jamel Chelly; Pierre Billuart
Journal:  Hum Mol Genet       Date:  2009-04-28       Impact factor: 6.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.